Gerresheimer stock slides after a 2026 outlook cut
Published on 08/17/2026 at 06:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Gerresheimer stock came under pressure after a report on August 16, 2026 said the company expects 2026 revenue in the lower half of its EUR 2.3 billion to EUR 2.4 billion range, while the shares closed at EUR 27.08 on August 15, 2026.
Guidance is the key number
The same report said the stock was 42 percent below its 52-week high of EUR 46.74, which was set in August 2025, and that the 50-day moving average stood at EUR 27.11. That puts the market reaction into a simple frame: the current quote sat just below a widely watched technical level.
For investors, the larger issue is the shape of the 2026 revenue path. A forecast centered on the lower half of the EUR 2.3 billion to EUR 2.4 billion range implies a slower finish to the year than many holders wanted after the earlier slide in the share price.
What the stock still reflects
The reported close of EUR 27.08 leaves the company far from its August 2025 peak, and the EUR 27.11 50-day average shows how tight the recent trading band has become. That is a narrow setup for a name whose valuation has already absorbed a steep rerating.
Historically, the stock price also highlights the tension between execution and expectations. A move of 42 percent below the 52-week high is large enough to keep every new update on guidance under close review.
Product and business angle
Gerresheimer's packaging and delivery systems for injectable drugs remain central to the story because that business is tied directly to pharmaceutical demand and customer order visibility. The latest revenue guidance is therefore not just a quarterly data point; it is a read on how that core end market is translating into sales.
Stock level to watch
The shares last closed at EUR 27.08 on August 15, 2026, just under the EUR 27.11 50-day average and well below the EUR 46.74 52-week high. That makes the next move more dependent on whether the revenue outlook changes than on the short-term tape alone.
Company details
Company: Gerresheimer AG
ISIN: DE000A0LD6E6
Ticker: GXI
Exchange: Xetra
Sector / Industry: Chemicals / Pharmaceuticals and healthcare packaging
Index membership: SDAX
